Institutional Ownership Karyopharm Therapeutics Inc. (KPTI)
This table provides information about the institutional ownership of Karyopharm Therapeutics Inc. (KPTI). We have compiled data on the 98 institutions that hold shares in the stock, with a total of 57.1 Million shares, which have been reported (via 13F filing form) to have a value of $34.8 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Birchview Capital, LP
Burlington, VT |
Feb 14, 2025 Q4 2024 |
419,832
shares
|
$260,295
0.24% of portfolio
|
Q4 2024
Reduced 10.64%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
408,899
shares
|
$253,517
0.05% of portfolio
|
Q4 2024
Reduced 0.11%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
342,847
shares
|
$212,565
0.0% of portfolio
|
Q4 2024
Reduced 6.96%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
328,807
shares
|
$203,860
0.0% of portfolio
|
Q4 2024
Reduced 33.74%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
283,729
shares
|
$175,911
0.0% of portfolio
|
Q4 2024
Added 23.54%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
276,208
shares
|
$171,248
0.0% of portfolio
|
Q4 2024
Reduced 80.07%
|
|
|
Atom Investors LP
Austin, TX |
Feb 14, 2025 Q4 2024 |
259,824
shares
|
$161,090
0.02% of portfolio
|
Q3 2024
Reduced 0.77%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Feb 14, 2025 Q4 2024 |
239,500
shares
|
$148,490
0.0% of portfolio
|
Q3 2024
Reduced 9.45%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
229,685
shares
|
$142,404
0.0% of portfolio
|
Q4 2024
Reduced 78.07%
|
|
|
Exchange Traded Concepts, LLC
|
Jan 21, 2025 Q4 2024 |
218,791
shares
|
$135,650
0.0% of portfolio
|
Q3 2024
Added 34.91%
|
|
|
Shay Capital LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
172,153
shares
|
$106,734
0.02% of portfolio
|
Q4 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
161,708
shares
|
$100,258
0.0% of portfolio
|
Q4 2024
Reduced 29.37%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
145,791
shares
|
$90,390
0.0% of portfolio
|
Q4 2024
Added 8.41%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
137,786
shares
|
$85,427
0.0% of portfolio
|
Q4 2024
Added 60.35%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
134,112
shares
|
$83,149
0.0% of portfolio
|
Q1 2024
Added 14.9%
|
|
|
Opti Capital Management, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
125,000
shares
|
$77,500
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
105,679
shares
|
$65,520
0.0% of portfolio
|
Q4 2024
Reduced 0.01%
|
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
101,700
shares
|
$63,054
0.01% of portfolio
|
Q3 2022
Added 101600.0%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
95,611
shares
|
$59,278
0.0% of portfolio
|
Q4 2024
Reduced 0.16%
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
90,635
shares
|
$56,193
0.0% of portfolio
|
Q4 2024
Reduced 0.5%
|
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
Feb 14, 2025 Q4 2024 |
84,698
shares
|
$52,512
0.02% of portfolio
|
Q4 2024
Added 2.73%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
76,600
shares
|
$47,492
0.0% of portfolio
|
Q4 2024
Added 145.51%
|
|
|
Prudential Financial Inc
Newark, NJ |
Feb 11, 2025 Q4 2024 |
74,600
shares
|
$46,252
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
64,300
shares
|
$39,866
0.0% of portfolio
|
Q4 2024
Reduced 52.26%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
51,173
shares
|
$31,727
0.0% of portfolio
|
Q4 2024
Added 0.34%
|